M. K. Fang, L. Chen and S. Q. Lu* Department of Anesthesiology, Hubei Cancer Hospital, Wuhan, 430079, Hubei, China. Keywords: sevoflurane; cervical cancer; Hippo-YAP/TAZ pathway; tumor volume; migration Open Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/). INTRODUCTION Cervical malignancy is a cause of poor prognosis and treatment failure in oncology.
